✦ LIBER ✦

Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens

✍ Scribed by Hiroshi Miyakawa; Atsushi Tanaka; Kentaro Kikuchi; Masanao Matsushita; Eriko Kitazawa; Naomi Kawaguchi; Hirotoshi Fujikawa; M.Eric Gershwin

Book ID: 111721574
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 118 KB
Volume: 34
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2001.26514

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beneficial hepatic effect of troglitazon

Beneficial hepatic effect of troglitazone in a patient with antimitochondrial antibody-negative primary biliary cirrhosis

✍ Takashi Okai; Hisatsugu Mouri; Yasushi Yamaguchi; Yasuni Nakanuma; Norio Sawabu 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 40 KB

The predominance of IgG3 and IgM isotype

The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis

✍ Charles D. Surh; Anne E. Cooper; Ross L. Coppel; Patrick Leung; Aftab Ahmed; Rol 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

Autoantibodies against inner mitochondrial membrane proteins are a hallmark of primary biliary cirrhosis. Specifically, these antimitochondrial autoantibodies recognize two polypeptides of approximately 70 and 52 kD, respectively. Although the specificity of antimitochondrial autoantibodies has been

Detection of Gp210 autoantibodies in pri

Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope

✍ Flora Tartakovsky; Howard J. Worman 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 749 KB

Autoantibodies against nuclear pore membrane glycoprotein gp210 have been identified in between 10% and 25% of patients with primary biliary cirrhosis (PBC). These antibodies may be useful in diagnosing PBC and in identifying subgroups of patients. Because previous detection procedures relied on the

Abnormal expression of PDC-E2 on the api

Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis

✍ Koichi Tsuneyama; Judy van de Water; David van Thiel; Ross Coppel; Boris Ruebner 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 945 KB

The presence of antimitochondrial antibodies (AMA) is a major criterion for the diagnosis of primary biliary cirrhosis (PBC). Although it is not clear that AMA are involved in the pathogenesis of the disease, the study of these autoantibodies has enabled much information to be accumulated about the

Antimitochondrial autoantibodies of prim

Antimitochondrial autoantibodies of primary biliary cirrhosis as a novel probe in the study of 2-oxo acid dehydrogenases in patients with mitochondrial myopathies

✍ Herawati Sudoyo; Sangkot Marzuki; Ian Trounce; Edward Byrne 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 674 KB

Quantitative measurement of autoantibodi

Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: Relationship of levels of autoantibodies to disease progression

✍ Michael D. Van Norstrand; Michael Malinchoc; K. D. Lindor; T. M. Therneau; M. E. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

## AMAs are detectable by indirect immunofluorescence (IF) We examined the clinical usefulness of measurements on tissue substrates in 93% to 99% of patients with PBC, but of antimitochondrial autoantibodies (AMA) in prethis method also detects AMAs of differing specificities in dicting disease pr